# Per-Lens Debate Transcripts
## Loe et al. 2025 — PAIR-GEE Stress-Test (2026-04-23)

**Reviewer backend:** subagent (Opus)  
**Author backend:** subagent (Sonnet)  

---

## Lens 0: DATA  —  MAJOR  (—)

**Finding:** No empirical justification for administrative censoring independence (C_i ⊥ gap times) in clinical settings where prolonged at-risk states predict LTFU; IPW handles in-event selection but not state-dependent administrative censoring.

**Author's best defense:** Paper reframes in-event selection as IPW missingness correction; Tayob-Murray transformation avoids dependent censoring from gap times

**Why it didn't hold:** Reviewer correctly identified the empirical justification gap: Assumption 1 handles selection from in-event state but C_i ⊥ T_{i,j} assumed unconditionally — unverified in clinical settings where prolonged at-risk state predicts LTFU

### Transcript

**REVIEWER (Round 1)**

QUESTION: Your IPW pseudo-observation framework presupposes censoring is independent of the alternating gap-time process conditional on covariates, yet in clinical settings (hospital readmission, infection-recovery cycles) patients in prolonged at-risk states are systematically more likely to be lost to follow-up — how do you justify this conditional independence empirically, and what is the bias when censoring depends on the latent state (in-event vs. between-event)?

**AUTHOR (Round 1)**

ANSWER: Paper restricts censoring independence to administrative C_i. In-event selection reframed as IPW missingness (Assumption 1: R_i(t) ⊥ T_i(t)|W_i(t)). Avoids dependent-censoring-gap-time issue via Tayob-Murray transformation. Simulation shows degraded performance under H_n and hazard changes. No analytic bias formula for state-dependent administrative censoring.

*Citations:*
- Ci is independent of T_{i,j}^{(1)}, T_{i,j}^{(2)} — Section 2
- Assumption 1 (Ignorability): R_i(t) ⊥ T_i(t)|W_i(t) — Section 4
- All methods struggled under hazard change — Section 6
- consistent under coverage after hazard change — Discussion

**MODERATOR (Round 1)**



*Signal: converging · Decision: close_lens*

**REVIEWER (TERMINAL)**

JUDGMENT: cited
REASONING: Author cites precise scope of independence assumption (Section 2, 4) and concedes no analytic bias formula for state-dependent administrative censoring — but the empirical justification for C_i ⊥ gap times in clinical settings where prolonged at-risk states predict LTFU is entirely unaddressed.
NEXT: FINAL
SEVERITY: major

---

## Lens 1: ESTIMAND  —  MAJOR  (—)

**Finding:** GEE coefficient beta never gets a target marginal distribution over (t,state) pairs defined; grid-dependent mixing weights and transportability undiscussed.

**Author's best defense:** beta defined as population-averaged marginal on RMST for all n(t) subjects via IPW; within-subject correlation handled by sandwich SEs

**Why it didn't hold:** No marginal distribution over (t,state) pairs defined; beta is grid-and-cohort-specific weighted average whose mixing weights are implicit and undiscussed

### Transcript

**REVIEWER (Round 1)**

QUESTION: T=next or any? secondary-state subjects at landmark? clock convention? multi-cycle contributions?

**AUTHOR (Round 1)**

T_i(t)=residual time to next primary event via eta. R_i(t)=0 subjects handled by IPW (Theorem 1). Clock at t unconditionally. GEE + sandwich SEs.

*Citations:*
- eta_i^(1)(t) definition — Section 3
- Theorem 1 — Section 4
- Figure 1 Panel (C)

**MODERATOR (Round 1)**



*Signal: progressing · Decision: continue*

**REVIEWER (Round 2)**

FOLLOWUP: What is the marginal interpretation of beta when same subject contributes from heterogeneous states across landmarks?

**AUTHOR (Round 2)**

beta is population-averaged marginal on RMST. CONCEDED: paper never defines marginal distribution over (t,state) pairs; grid-dependence undiscussed; no transportability claim.

*Citations:*
- GEE estimating equation — Section 4
- Theorem 1
- target population statement — Section 4

**MODERATOR (Round 2)**



*Signal: converging · Decision: close_lens*

**REVIEWER (TERMINAL)**

JUDGMENT: conceded
REASONING: Paper never defines target marginal distribution over (t,state); grid-dependent mixing weights undiscussed.
NEXT: FINAL
SEVERITY: major

---

## Lens 2: IDENTIFICATION  —  MAJOR  (—)

**Finding:** No positivity diagnostics; no formal unmeasured-frailty sensitivity analysis (E-values/Rosenbaum bounds); engineering of W_i(t) and simulation sweeps are partial mitigations only.

**Author's best defense:** W_i(t) engineered with event-history summaries including reflective-history predictors; simulation sweep across 7 history-degradation scenarios

**Why it didn't hold:** No applied positivity diagnostic; no formal sensitivity analysis for unmeasured frailty jointly predicting at-risk status and next gap time

### Transcript

**REVIEWER (Round 1)**

QUESTION: Ignorability where W_i(t) has coarse history; frailty unaddressed; Assumption 2 tautological; no positivity diagnostic; no sensitivity analysis.

**AUTHOR (Round 1)**

W_i(t) engineered with event-history summaries mechanically related to R_i(t); reflective-history predictors near-perfectly predict R_i(t) retrospectively; Assumption 2 is standard exclusion restriction; simulation sweep across 7 history-degradation scenarios; CONCEDED: no positivity diagnostics, no formal frailty sensitivity analysis.

*Citations:*
- Assumption 1 — Section 4
- W_i(t) construction — Section 5
- reflective history — Section 5
- Theorem 1 positivity bound
- H_n failure — Section 6
- hazard change under-coverage — Section 8

**MODERATOR (Round 1)**



*Signal: converging · Decision: close_lens*

**REVIEWER (TERMINAL)**

JUDGMENT: conceded
REASONING: Authors concede no positivity diagnostic and no formal unmeasured-frailty sensitivity; simulation sweeps do not close the frailty/ignorability critique.
NEXT: FINAL
SEVERITY: major

---

## Lens 3: METHODOLOGY  —  MAJOR  (—)

**Finding:** No formal sqrt(n)/influence-function proof for sandwich SE validity under nonparametric RF weights; single n=750 simulation; coverage contingent on covariate quality.

**Author's best defense:** Theorem 1 is correct finite-sample identification. Out-of-bag argument for consistency. Empirical coverage 0.918-0.969 under good weight spec. Covariate-quality typology (H_f to H_n) is the practical diagnostic.

**Why it didn't hold:** No formal sqrt(n) asymptotic linearity or influence function; sandwich SE validity under nonparametric RF weights not established; n=750 only — no sample-size sensitivity analysis.

*[Transcript compacted to summary bullets in state.json]*

---

## Lens 4: OVERCLAIMS  —  MAJOR  (—)

**Finding:** No doubly-robust/oracle benchmark to bound residual bias when RF propensity is itself misspecified; 'avoids bias' precisely bounded but single-robustness never acknowledged.

**Author's best defense:** 'Avoids bias' precisely bounded to structural missingness. 'Substantially improves' refers to history covariates for RF. No double-robustness claim made. Real data uses hedged associational language.

**Why it didn't hold:** No doubly-robust/oracle benchmark included; impossible to bound residual bias when RF propensity is itself misspecified.

*[Transcript compacted to summary bullets in state.json]*

---

## Lens 5: ALTERNATIVES  —  MAJOR  (—)

**Finding:** No AIPW/TMLE/doubly-robust alternative; no shared-frailty joint model benchmark; single-robustness of IPW never acknowledged; only comparator is unweighted GEE.

**Author's best defense:** Paper scope narrowly stated (structural missingness correction). RF gains contingent on history covariate quality (H_n failure documented).

**Why it didn't hold:** No AIPW/TMLE discussion anywhere in text; single-robustness of IPW not mentioned; only baseline is naive unweighted GEE.

*[Transcript compacted to summary bullets in state.json]*

---

## Lens 6: GENERALIZABILITY  —  MAJOR  (partial)

**Finding:** H_{p*} enters only IPW weight model (legitimate structural defense) but paper pitched for clinical settings without disclosing retrospective-only operability; no decomposition separating genuine correction from H_{p*}-encoded outcome-direction propagation through reweighted GEE.

**Author's best defense:** Paper explicitly scopes to retrospective clinical trial data-lock setting; H_{p*} enters weight model for R_i(t) only, not outcome model for T_i(t); structural separation is logically correct per GEE estimating equation.

**Why it didn't hold:** R_i(t) mechanically coupled to T_i(t); near-oracle H_{p*} encodes outcome direction into IPW weights; no corrupted-H_{p*} sensitivity analysis or prospective-surrogate simulation exists; paper pitched for clinical settings (CareQOL) without disclosing prospective-deployment limitation.

### Transcript

**REVIEWER (Round 1)**

QUESTION: Your entire inferential engine rests on a reflective history predictor H_i(t) that encodes whether subject i's next post-t transition is to the secondary state — information that, by construction, is unavailable in any genuinely prospective deployment (clinical dashboards, risk-scored enrollment, real-time caregiver triage in CareQOL itself) where t is 'now' and the future is unobserved; given that the n=750 simulation, the CareQOL application, and every reported C-index are all retrospective with the full trajectory in hand, what empirical evidence do you offer that the method's predictive performance, calibration, and IPW weight stability survive the transition to a prospective setting where H_i(t) must be replaced by a forecast or a censored surrogate, and why should a reader believe the reported gains are not an artifact of peeking past the landmark?

**AUTHOR (Round 1)**

ANSWER: Paper explicitly scopes to retrospective clinical trial data-lock analysis. H_{p*} enters only IPW weight model for R_i(t), not outcome model for T_i(t). "We are not using future primary alternating recurrent event times to predict current primary alternating recurrent event times." No prospective simulation, no degradation analysis with forecasted H_i(t) exists in the paper.

*Citations:*
- "we are simply using future, already observed primary and secondary event types to better fit a model for R_i(t)" — Section 5
- "covariates that may perfectly predict min(T_i(t), τ) are permissible for use in our random forest algorithm" — Section 5
- "it performs almost as poorly as the unweighted model" — Section 6 (H_n setting)
- "Important work in the future may consider kernel density-type calculations of history covariates" — Section 8

**MODERATOR (Round 1)**



*Signal: converging · Decision: continue*

**REVIEWER (Round 2)**

FOLLOWUP: R_i(t) mechanically entangled with T_i(t); H_{p*} that perfectly predicts at-risk status encodes outcome direction into weights; can you provide decomposition or corrupted-H_{p*} simulation separating genuine correction from proxy-oracle gains?

**AUTHOR (Round 2)**

ANSWER: Paper does not contain any such decomposition. Factual correction: evaluation metric is GEE bias/coverage, not C-index. Structural separation (H_{p*} in weight model only) is paper's full defense. H_{p4}/H_n degradation simulations vary historical information but do not isolate retrospective vs. prospective component. No decomposition, no sensitivity analysis separating genuine bias correction from information leakage through reweighted GEE equations.

*Citations:*
- "we are simply using future, already observed primary and secondary event types to better fit a model for R_i(t)" — Section 5
- "it performs almost as poorly as the unweighted model" — Section 6 (H_n)
- "Important work in the future may consider kernel density-type calculations of history covariates" — Section 8

**MODERATOR (Round 2)**



*Signal: converging · Decision: close_lens*

**REVIEWER (TERMINAL)**

JUDGMENT: partial
REASONING: Paper offers legitimate structural defense (H_{p*} in weight model only; retrospective data-lock scope). But: (i) R_i(t) mechanically coupled to T_i(t) so outcome-direction information propagates through reweighted GEE; no decomposition or corrupted-H_{p*} sensitivity exists. (ii) Paper pitched for clinical settings (CareQOL) without disclosing H_{p*} unavailable prospectively — scope tension undisclosed.
NEXT: FINAL
SEVERITY: major

---

## Lens 7: POSITIONING  —  MAJOR  (partial)

**Finding:** τ-RMST estimand choice is genuinely supported (Royston & Parmar 2013; Chemo A example) but state-conditioning incompatibility argument vs. frailty comparators never articulated in manuscript; IPW logistic ablation absent; novelty over Loe et al. 2025 asserted not demonstrated.

**Author's best defense:** State-conditional τ-RMST is non-trivial to recover from frailty models without landmark-compatible secondary gap-time identification (non-standard conditioning). Chemo A motivating example shows real confound. Royston & Parmar (2013) cited for clinical relevance of τ-RMST.

**Why it didn't hold:** State-conditioning incompatibility argument not in manuscript — emerged under adversarial pressure only. IPW logistic regression baseline absent, so RF-vs.-any-IPW decomposition unavailable. Novelty over Loe et al. 2025 not demonstrated empirically.

### Transcript

**REVIEWER (Round 1)**

QUESTION: Benchmark only against unweighted GEE — never Wang et al. 2020, Li et al. 2017, bivrec, or IPW logistic baseline. Cannot decompose gains. Novelty over Loe et al. 2025 not demonstrated.

**AUTHOR (Round 1)**

ANSWER: Full concession. Simulation goals: unweighted GEE comparison + history covariate demonstration only. Principled competitors appear only in introduction citation cluster. No RF-vs.-parametric-IPW decomposition. Novelty asserted, not demonstrated.

*Citations:*
- "The goals of our simulation study are two fold: (1) to compare the performance of PAIR-GEE models to a complete case (unweighted) analysis... and (2) to demonstrate the importance of including history covariates" — Section 6
- Wang/Li/Castro-Pearson appear only in introduction citation cluster — Introduction

**MODERATOR (Round 1)**



*Signal: converging · Decision: continue*

**REVIEWER (Round 2)**

FOLLOWUP: Is τ-RMST an artificial moat that defines away competition, or genuinely incomparable to frailty hazard models? Either justify on clinical grounds or concede framing artifact.

**AUTHOR (Round 2)**

ANSWER: Genuine substantive defense. State-conditional τ-RMST is the estimand; frailty models suffer same Chemo A confound naively; producing state-conditional RMST from frailty model requires non-trivial landmark conditioning not implemented by Wang et al. 2020 or Li et al. 2017. Royston & Parmar cited. Conceded: incompatibility argument not in manuscript; IPW logistic baseline absent.

*Citations:*
- "changes in T_i^(1)(t) for R_i(t) = 0 are a function of both the primary and secondary types of events, which cannot be untangled in a GEE approach" — Section 4
- "this may lead to an analyst concluding that Chemo A... is a superior treatment... However, the observed increase was due to an increase in the secondary alternating recurrent event" — Section 4
- "tau-restricted mean time-to-event uses tau to focus inference on clinically relevant horizons... (Royston and Parmar, 2013)" — Section 4

**MODERATOR (Round 2)**



*Signal: converging · Decision: close_lens*

**REVIEWER (TERMINAL)**

JUDGMENT: partial
REASONING: τ-RMST estimand choice genuinely supported in-text (Royston & Parmar; Chemo A). But state-conditioning incompatibility argument not in manuscript — emerged only under adversarial pressure. IPW logistic ablation absent. Novelty over Loe et al. 2025 asserted not demonstrated.
NEXT: FINAL
SEVERITY: major

---

## Lens 8: REPRODUCIBILITY  —  MINOR  (partial)

**Finding:** DGP fully specified; pseudo-observation formula explicit with pseudomean R pointer; GitHub code available. Seed protocol absent from manuscript (GitHub only); CareQOL Figure 5 not independently verifiable (DUA/IRB constraint).

**Author's best defense:** Complete DGP spec (piecewise hazards, Laplace censoring, landmark grid); PO = n_R(t)*theta_hat - (n_R(t)-1)*theta_hat_{-i}; pseudomean R function as independent implementation path; CareQOL restriction is standard clinical data access.

**Why it didn't hold:** Seed protocol not in manuscript (Monte Carlo results cannot be bit-reproduced from paper alone); Figure 5 real-data analysis foreclosed by DUA. Both are standard limitations.

### Transcript

**REVIEWER (Round 1)**

QUESTION: Seed protocol undisclosed; DGP at summary level; landmark grid unstated; CareQOL data behind 'available upon request' — can paper be reproduced without GitHub, and is Figure 5 independently verifiable?

**AUTHOR (Round 1)**

ANSWER: DGP full — piecewise hazards, Laplace censoring, landmark grid explicitly stated (t in {0..11} months, tau=1; CareQOL: t in {0,2,4,6,8,10} weeks, tau=2). PO formula fully stated; pseudomean R function referenced. Seed: CONCEDED — not in manuscript, GitHub only. KM bandwidth: N/A (standard jackknife). CareQOL: available upon reasonable request (NCT04570930), standard DUA constraint.

*Citations:*
- "POτ_i(t) = nR(t)θ̂(t) − {nR(t) − 1}θ̂_{-i}(t), which can be easily obtained using the pseudomean function from the survival package" — Section 4
- "The CareQOL data that support the findings in this paper are available upon reasonable request. The R code for reproducing the simulation and data analysis is accessible via http://github.com/AbigailLoe/pair_gee" — Data Availability Statement
- "t ∈ {0, 1, 2, . . . 11} months with τ = 1 month" — Simulation section
- "t ∈ {0, 2, 4, 6, 8, 10} weeks" — Section 7

**REVIEWER (TERMINAL)**

JUDGMENT: partial
REASONING: DGP and formula fully specified; pseudomean R reference gives independent implementation path. Seed protocol absent (GitHub-only), so Monte Carlo results not bit-reproducible from paper alone. Figure 5 foreclosed by DUA — standard but a genuine limitation for this lens.
NEXT: FINAL
SEVERITY: minor

---
